Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (111-120 of 219) with videos related to

Pageof 22
Sort By:
Pathogens & Immunity|October 5, 2019
Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab UseBrett B Williams, Stefan J Green, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapyLesia Semenova, Yingfan Wang, Shane Falcinelli, et al.
Elife|September 9, 2024
Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapyLesia Semenova, Yingfan Wang, Shane Falcinelli, et al.
Plos One|August 20, 2014
Selective HDAC inhibition for the disruption of latent HIV-1 infectionKirston M Barton, Nancie M Archin, Kara S Keedy, et al.
The Journal of Infectious Diseases|April 17, 2007
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170Daniel J Skiest, Zhaohui Su, Diane V Havlir, et al.
Plos Pathogens|November 30, 2016
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro ModelCory H White, Bastiaan Moesker, Nadejda Beliakova-Bethell, et al.
Plos Pathogens|December 6, 2023
Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized miceLijun Ling, Chandrav De, Rae Ann Spagnuolo, et al.
The Journal of Infectious Diseases|September 21, 2004
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donorsLoyda Ylisastigui, Jason J Coull, Victor C Rucker, et al.
Iscience|January 13, 2022
Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52Dajiang Li, Morgan G Dewey, Li Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationMichael J Vinikoor, Anna Cope, Cynthia L Gay, et al.
Pageof 22

Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Pathogens & Immunity|October 5, 2019
Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab UseBrett B Williams, Stefan J Green, Ronald J Bosch, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapyLesia Semenova, Yingfan Wang, Shane Falcinelli, et al.
Elife|September 9, 2024
Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapyLesia Semenova, Yingfan Wang, Shane Falcinelli, et al.
Plos One|August 20, 2014
Selective HDAC inhibition for the disruption of latent HIV-1 infectionKirston M Barton, Nancie M Archin, Kara S Keedy, et al.
The Journal of Infectious Diseases|April 17, 2007
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170Daniel J Skiest, Zhaohui Su, Diane V Havlir, et al.
Plos Pathogens|November 30, 2016
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro ModelCory H White, Bastiaan Moesker, Nadejda Beliakova-Bethell, et al.
Plos Pathogens|December 6, 2023
Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized miceLijun Ling, Chandrav De, Rae Ann Spagnuolo, et al.
The Journal of Infectious Diseases|September 21, 2004
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donorsLoyda Ylisastigui, Jason J Coull, Victor C Rucker, et al.
Iscience|January 13, 2022
Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52Dajiang Li, Morgan G Dewey, Li Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationMichael J Vinikoor, Anna Cope, Cynthia L Gay, et al.
Pageof 22